No Detail Found!

Incidence of Acute Endophthalmitis after Office Based Intravitreal Bevacizumab Injection.

Author(s)
Muhammad Ali Haider Al-Ehsan Welfare Eye Hospital,Lahore, Pakistan
Usman Imtiaz Al-Ehsan Welfare Eye Hospital, Pakistan
Farwah Javed Lahore General Hospital, Lahore, Pakistan
Zahra Haider KRL Hospital, Islamabad,Pakistan
Abstract
The burden of intravitreal injections has increased tremendously over the past few years. Since traditionally the operation theatre setup is currently used for this procedure, it is increasingly becoming difficult to manage such a patient load in the theatres. To overcome this challenge, office-based setup for intravitreal injection was started. This study was planned to determine the incidence of endophthalmitis after officebased intravitreal bevacizumab injection and to compare it with previously reported incidence of endophthalmitis after operation theatre-based intravitreal injections. The study was conducted at Al-Ehsan Eye Hospital, Lahore, Pakistan, from July 2015 to June 2016, and comprised patients who received intravitreal injections of bevacizumab (Avastin) for different ocular indications. A total of 1,047 intravitreal injections were given in an office-based set-up. Of them, 2(0.19%) cases of clinically suspected endophthalmitis were identified. Office-based set-up for intravitreal bevacizumab injection was found to have comparable safety profile with traditional operation theatre-based set-up.
Publication Details
Page(s) 1917-1919
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 67, Issue: 12, Year: 2017

Request the full text from PASTIC

References
ArevaloJF,Fromow-GuerraJ,Quiroz-MercadoH,SanchezJG,WuL,MaiaM,,2007,Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: result from the Pan-American Collaborative Retina Study Group at 6-month follow up,Ophthalmology,114,743,50
TabandehH,BosciaF,SborgiaA,FlynnHW,,2014,Endophthalmitis associated with intravitreal injections: Office-based setting and operating room setting,Retina,34,18,23
WuL,Marinez-CastellanosMA,Quiroz-MercadoH,ArevaloJF,BerrocalMH,FarahME,,,Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American 4,,,,
AmoakuW,PearceI,BrowningA,,2009,,Guidelines for Intravitreal Injections Procedure,,,
GuptaOP,ShienbaumG,PatelAH,FecarottaC,KaiserRS,RegilloCD,,2010,A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration. Clinical and economic impact,Ophthalmology,117,2134,40
FiletaJB,ScottIU,FlynnHW,DoshiRR,LengT,FungAE,Povidone-Iodine Before Lidocaine Gel Anesthesia Achieves Surface Antisepsis,,2011,Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents,Ophthamic Surg Lasers Imaging,42,346,9
Doshi RR, Leng T, Fung AE. Povidone-Iodine Before Lidocaine Gel Anesthesia Achieves Surface Antisepsis. Ophthamic Surg Lasers Imaging 2011; 42: 346-9.
D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunnigham ET Jr, Guyer DR, et al; VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N) Clinical Trial Group. Pegatanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, muticenter, controlled clinical trials. Ophthalmology 2006; 113: 992-1001.
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperaytive bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995; 113: 1479-96.
0

Citations

0

Downloads

72

Views